Founded in 2008, the BioNTech Group has become one of the fastest-growing biotechnology companies in Europe. The development of fundamentally novel, cutting-edge biopharmaceuticals for treatment of many diseases with high medical need drives our success.
We are committed to serving patient needs by making medicine truly personal. Our vision is to offer precisely targeted, highly effective, and well-tolerated therapies – innovative medicines as unique as you!
|MERIT||RNA-based cancer vaccine targeting two tumor-associated antigens (Malignant Melanoma)|
|IVAC MUTANOME||Two RNA-based cancer vaccines targeting two tumor-associated antigens as well as tumor-specific mutations (Malignant Melanoma)|
|GAPVAC||Actively personalized vaccination concept in newly diagnosed glioblastoma patients (Glioblastoma)|
|TNBC-MERIT||RNA-lipoplex cancer vaccines targeting tumor-associated antigens (IVAC®WAREHOUSE) as well as tumor-specific mutations (IVAC® MUTANOME) (Triple negative breast cancer)|
|Lipo-MERIT||RNA-lipoplex cancer vaccine targeting four tumor-associated antigens (Malignant Melanoma)|
Interested in meeting with us?
Please contact our Business Development Department
The Times – Vaccine found to beat cancer mutations
BioWorld – BioNTech gives scientific rationale for personalized RNA cancer vaccines
Spektrum – Rückt die maßgeschneiderte Immuntherapie gegen Krebs näher?
SWR Rheinland-Pfalz – Report on vaccines against cancer
Science Media Centre – Expert reaction to study investigating cancer immunotherapy in mice
The Indepentent – ‘Personalised’ cancer vaccine moves a step closer
Daily Mail – Personalised drugs could revolutionise the war on cancer
Huffington Post – Cancer Research Moves Towards Revolutionary Personalised Vaccines
Health Day – Vaccine Spurs Immune Response to Fight Aggressive Cancers in Mice
eCancerNews – Mouse models show tailored immunotherapy to be effective
Medizin Aspekte – Auf dem Weg zu einer individualisierten Immuntherapie bei Krebs
AZ – Wissenschaftler setzen auf neuen Therapieansatz bei der Bekämpfung von Tumoren
Fusion – Personalized cancer-fighting vaccines are on their way
Jura Forum – Auf dem Weg zu einer individualisierten Immuntherapie bei Krebs
Jersey Evening Post – ‘Personal vaccine’ to target cancer